 "Glenmark Life Sciences to open July 27 with 6.3 mn shares on sale")
The initial public offering of Glenmark Life Sciences will open on July 27 and close on July 29, parent Glenmark Pharmaceuticals said in regulatory filing on Tuesday. Glenmark Pharma will sell 6.3 million shares in the company. The IPO will also consist of fresh fund raise to the tune of Rs 1,060 crore.
Glenmark Life Sciences is a manufacturer of active pharmaceutical ingredients (API) with a portfolio of 120 products. Currently, Glenmark Pharma holds a 100 per cent stake in the company.
Anand Rathi Wealth files IPO document with Sebi
Anand Rathi Wealth has filed its draft red herring prospectus with market regulator Sebi. The IPO will entirely be an offer for sale by existing shareholders, including founder Anand Rathi. The company offers wealth solutions, financial product distribution and technology solutions. Currently, the only listed player in the category is IIFL Wealth, which has a market cap of Rs 12,180 crore.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%